MAY 08, 2018 9:01 PM PDT

Pure Form of An Illegal Euphoric Drug Treats PTSD

WRITTEN BY: Nouran Amin

 

Post-traumatic stress disorder (PTSD) is a psychiatric disorder where an individual has a difficult time recovering from a traumatic incident often caused by re-occurring memories of the situation leading to mental distress. According to the National co-morbidity published by Harvard Medical School, about 7% of people in the United States will suffer from PTSD during their lifetimes. Although many patients improve with therapy, anti-depressant medications and time, some will continue to have nightmares or flashbacks that persistently allow them to re-live a traumatic event. These patients will often experience severe symptoms that range from triggered anxiety attacks to depression, sleep disturbances, and dramatic changes in mood and behavior.

 

Now, an illegal euphoric drug may seek to treat individuals suffering from PTSD. The pure chemical form or active ingredient of this particular drug is MDMA (3,4-methylenedioxymethamphetamine). MDMA is known to alter mood and perception by targeting brain cells to release the neurohormone serotonin which is a brain chemical that regulates mood, aggression, sexual activity, sleep patterns and pain sensitivity. MDMA is also chemically the same as stimulants and hallucinogens.

Mental health investigators were curious if the chemical proteins of MDMA could be therapeutic for a multitude of metal health disorders. Dr. Michael Mithoefer, M.D., a psychiatrist who studies MDMA-assisted psychotherapy, described MDMA as "unique among drugs that decrease anxiety in that it isn’t sedating and doesn’t impair memory."

"People have clear recall of trauma without being overwhelmed by emotions or dissociating and being emotionally numb," he continues. "Our model is that MDMA is acting as a catalyst to the psychotherapeutic process, not as a stand-along drug."

MDMA was approved by the FDA for classic studies in treating chronic PTSD, but only under certain conditions. Regardless, it was seen that MDMA is the effective choice. “PTSD involves prominent fear responses and the fact that MDMA decreases fear by decreasing activity in the amygdala and increasing activity in prefrontal cortex," explains Mithoefer.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 21, 2020
Cannabis Sciences
APR 21, 2020
Is CBD Effective Against Women's Health Issues?
Products containing cannabidiol (CBD) are increasingly known as a natural and effective way to handle a wide range of wo ...
APR 23, 2020
Drug Discovery & Development
APR 23, 2020
Over 200 Volunteers Design $216 Ventilator for COVID-19
Over 200 volunteers from France have designed a ventilator suitable to treat COVID-19 patients that costs less than $500 ...
APR 25, 2020
Cannabis Sciences
APR 25, 2020
Researchers Trial Cannabis to Treat COVID-19
Researchers in Israel are investigating the potential for cannabis-derived products to treat patients with COVID-19. So ...
MAY 07, 2020
Cancer
MAY 07, 2020
Yet Another Cancer Linked Tyrosine Kinase
In a cell, there are tens of thousands of individual components. Each component has a specific activity or role that the ...
MAY 16, 2020
Cancer
MAY 16, 2020
Red Blood Cells: More than just an Oxygen Delivery Service
The human body is a complex network of systems that often interact and affect each other. Recent work shows that red blo ...
MAY 21, 2020
Drug Discovery & Development
MAY 21, 2020
Molecular 'Switch' Makes Autoimmune Drugs Fight Cancer
Researchers from the Antibody and Vaccine Group at the University of Southampton, England, have identified a way to repu ...
Loading Comments...